{
  "documentMetadata": {
    "title": "Ventricular Assist Device Infection",
    "lastUpdated": "2020-08-03",
    "sourceFile": "Ventricular Assist Device Infection.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Empiric therapy.",
        "Obtain cultures of the following: blood, wounds, drive line, device pocket and, maybe, the pump."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Staph. aureus",
        "Staph. epidermidis",
        "Aerobic Gram-negative bacilli",
        "Candida sp."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "regimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Vancomycin",
            "dose": "15-20 mg/kg",
            "route": "IV",
            "frequency": "q8-12h"
          },
          {
            "drug": "Cefepime",
            "dose": "2 gm",
            "route": "IV",
            "frequency": "q12h",
            "connector": "+"
          },
          {
            "drug": "Fluconazole",
            "dose": "800 mg",
            "route": "IV",
            "frequency": "q24h",
            "connector": "+"
          }
        ],
        "notes": "to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator; alternative is trough of 15-20 µg/mL)"
      }
    },
    {
      "type": "list",
      "items": [
        "Can substitute as follows:",
        "Daptomycin 10 mg/kg/day for Vancomycin",
        "(Ciprofloxacin 400 mg IV q12h or Levofloxacin 750 mg IV q24h) for Cefepime",
        "Voriconazole, Caspofungin, Micafungin or Anidulafungin for Fluconazole"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "list",
      "items": [
        "None"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "For definitive therapy, modify regimen based on results of culture and susceptibility tests."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "It is often not feasible to remove the device, so suppression is typically required after initial treatment course.",
        "Higher than FDA-approved dose for Daptomycin indicated because of potential for emergence of resistance.",
        "References: Clin Infect Dis 57:1438, 2013, Clin Infect Dis 64: 222, 2017."
      ]
    }
  ]
}
